Measuring hand grip strength in patients with type 2 diabetes
To Assess Prevalence of Sarcopenia Using Hand Grip Strength (HGS) as a Marker in Patients With T2DM
This study tests how strong the hand grip is in people with type 2 diabetes to see if it relates to muscle weakness and overall health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 20 Years to 60 Years |
| Sex | All |
| Sponsor | Diabetes Foundation, India Academic / other |
| Locations | 1 site (Delhi) |
| Trial ID | NCT05939908 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess hand grip strength in patients diagnosed with type 2 diabetes using a Jamar dynamometer. Participants will perform three trials of maximal grip strength, with readings taken in pounds and kilograms, to evaluate their muscle strength. The study focuses on understanding the relationship between hand grip strength and sarcopenia, a condition that can affect physical performance and quality of life in diabetic patients. The findings may provide insights into the prevalence of sarcopenia and its implications for diabetes management.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with type 2 diabetes who are visiting the outpatient department for the first time.
Not a fit: Patients with hand fractures, thyroid dysfunction, musculoskeletal conditions, or those with type 1 or gestational diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify patients at risk of sarcopenia and improve management strategies for type 2 diabetes.
How similar studies have performed: Previous studies have indicated a correlation between hand grip strength and diabetes prevalence, suggesting that this approach has been explored with some success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients with Type 2 diabetes of any duration coming for first time in OPD Exclusion Criteria: 1. Patients with hand fracture 2. Thyroid dysfunction 3. Any musculoskeletal condition causing difficulty in holding the dynamometer 4. Patients with type1 diabetes (T1DM) and gestational diabetes (GDM)
Where this trial is running
Delhi
- Fortis CDOC Hospital — Delhi, India (Recruiting)
Study contacts
- Principal investigator: Anoop Misra, MD — Fortis CDOC Hospital
- Study coordinator: Anoop Misra, MD
- Email: anoopmisra@gmail.com
- Phone: 01149101222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.